Hongxia Li, M. D. , Jiangang Chen, M. D. , James W Overstreet, M. D

Slides:

Advertisements

Similar presentations

Pregnancy rates after embryo transfer depend on the provider at embryo transfer22 Rhonda M Hearns-Stokes, M.D., Bradley T Miller, M.D., Lynette Scott,

Advertisements

Early-stage endometriosis: adhesion and growth of human menstrual endometrium in nude mice Michelle Nisolle, M.D., Ph.D., Françoise Casanas-Roux, B.S.,

High frequency of discordance between antimüllerian hormone and follicle-stimulating hormone levels in serum from estradiol-confirmed days 2 to 4 of the.

Sex Steroid Hormones Modulate Serum Ionized Magnesium and Calcium Levels Throughout the Menstrual Cycle in Women 1 Ozgul Muneyyirci-Delale, Vijaya L.

Relationships between the luteinizing hormone surge and other characteristics of the menstrual cycle in normally ovulating women Ana Direito, M.D., Sébastien.

Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection.

Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas Vera Grigorieva, MD, Mario Chen-Mok, PhD, Marina.

The normal variabilities of the menstrual cycle

Increasing uterine receptivity by decreasing estradiol levels during the preimplantation period in high responders with the use of a follicle-stimulating.

What is the optimal follicular size before triggering ovulation in intrauterine insemination cycles with clomiphene citrate or letrozole? An analysis.

Urinary reproductive hormone level differences between African American and Caucasian women of reproductive age Susan R Reutman, Ph.D., Grace Kawas LeMasters,

Neohormones as biomarkers of reproductive health

Growth rates of ovarian follicles during natural menstrual cycles, oral contraception cycles, and ovarian stimulation cycles Angela R. Baerwald, Ph.D.,

Rene Ecochard, M. D. , Ph. D. , Olivia Duterque, M. D. , Rene Leiva, M

Partnered sexual activity moderates menstrual cycle–related changes in inflammation markers in healthy women: an exploratory observational study Tierney.

Modified natural cycle in in vitro fertilization

Hakan Cakmak, M. D. , Audra Katz, R. N. , Marcelle I. Cedars, M. D

Subcutaneous versus intramuscular administration of human chorionic gonadotropin during an in vitro fertilization cycle James R. Stelling, M.D., Emily.

Zeev Shoham, M.D. Fertility and Sterility

Effect of short-term hormone therapy on oxidative stress and endothelial function in African American and Caucasian postmenopausal women Raymond W Ke,

Christine L Cook, M. D. , Yong Siow, Ph. D. , Susan Taylor, B. A

A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data

Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low- dose step-up protocol with weekly increments of 25 international.

Microdose follicular phase gonadotropin-releasing hormone agonists (GnRH-a) compared with luteal phase GnRH-a for ovarian stimulation at in vitro fertilization5

Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine.

Prevalence of premature urinary luteinizing hormone surges in women with regular menstrual cycles and its effect on implantation of frozen-thawed embryos

Chao-Chin Hsu, M. D. , Ph. D. , Hsin-Chih Kuo, Ph. D

Angela R. Baerwald, Ph. D. , Olufemi A. Olatunbosun, M. D. , Roger A

Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 μg) and ethinyl estradiol (15 μg) on ovarian activity Helen Sullivan,

A prospective randomized clinical trial of differing starter doses of recombinant follicle- stimulating hormone (follitropin-β) for first time in vitro.

Conversion of high-response gonadotropin intrauterine insemination cycles to in vitro fertilization results in excellent ongoing pregnancy rates Amy.

Jennifer Lucero, M. D. , Bernard L Harlow, Ph. D

Angela R Baerwald, B. Sc. Hon. , Gregg P Adams, D. V. M. , M. S. , Ph

Clinical Assessment of Recombinant Human Follicle-Stimulating Hormone in Stimulating Ovarian Follicular Development Before In Vitro Fertilization fn1

René Ecochard, M. D. Ph. D. , Agnes Guillerm, M. D. , René Leiva, M. D

Susanna J. Park, M. D. , Laura T. Goldsmith, Ph. D. , Joan H

Plasma matrix metalloproteinase activity during the menstrual cycle of healthy ovulatory patients who underwent tubal ligation Maher A. Abdallah, M.D.,

Tomer Singer, M. D. , David H. Barad, M. D. , M. S

Synchronization of ovarian stimulation with follicle wave emergence in patients undergoing in vitro fertilization with a prior suboptimal response: a.

Introduction Fertility and Sterility

Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D.

Effect of letrozole at 2. 5 mg or 5

Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: a meta-analysis Rina Agrawal,

Endometrial morphology and modulation of hormone receptors during ovarian stimulation for assisted reproductive technology cycles Laura Detti, M.D.,

Pete N. Lohstroh, B. S. , James W. Overstreet, M. D. , Ph. D

Perimenstrual asthma: A syndrome without known cause or cure

Concentrations of inhibins and activin in women undergoing stimulation with recombinant follicle-stimulating hormone for in vitro fertilization treatment

Comparison of two methods for the measurement of sperm concentration

Mean versus individual hormonal profiles in the menstrual cycle

Predictive usefulness of cycle day 10 follicle-stimulating hormone level in a clomiphene citrate challenge test for in vitro fertilization outcome in.

Hongxia Li, M. D. , Steven T Nakajima, M. D. , Jiangang Chen, M. D

Effectiveness of highly purified human menopausal gonadotropin vs

Regulation of assisted reproductive technologies in the United States

Decreased levels of interleukin-18 in peritoneal fluid but not in serum of patients with endometriosis Xinmei Zhang, M.D., Jun Lin, M.D., Yuli Qian,

Effects of metformin on body mass index, menstrual cyclicity, and ovulation induction in women with polycystic ovary syndrome Derek A Haas, M.D., Bruce.

Absence of corpus luteum rescue by chorionic gonadotropin in women immunized with a contraceptive vaccine Rahul Pal, Ph.D., Om Singh, Ph.D. Fertility.

Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing.

Hourly human chorionic gonadotropin secretion profiles during the peri-implantation period of successful pregnancies Pete N. Lohstroh, Ph.D, James W.

Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection.

Women with regular menstrual cycles and a poor response to ovarian hyperstimulation for in vitro fertilization exhibit follicular phase characteristics.

Economic evaluation of highly purified menotropin compared with recombinant follicle- stimulating hormone in assisted reproduction Adam Lloyd, M.Phil.,

M. Rafet Gazvani, Michelle Bates, Gillian Vince, Ph. D

Lower levels of inhibin A and pro-αC during the luteal phase after triggering oocyte maturation with a gonadotropin-releasing hormone agonist versus human.

First live birth after ovarian stimulation using a chimeric long-acting human recombinant follicle-stimulating hormone (FSH) agonist (recFSH-CTP) for.

Conception, early pregnancy loss, and time to clinical pregnancy: a population-based prospective study Xiaobin Wang, M.D., Changzhong Chen, M.D., Lihua.

Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles David.

Defining the “sweet spot” for administered luteinizing hormone-to-follicle-stimulating hormone gonadotropin ratios during ovarian stimulation to protect.

Conversion from assisted reproductive technology to intrauterine insemination in low responders: Is it advantageous? John M. Norian, M.D., Eric D. Levens,

A novel “delayed start” protocol with gonadotropin-releasing hormone antagonist improves outcomes in poor responders Hakan Cakmak, M.D., Nam D. Tran,

Use of recombinant human chorionic gonadotropin in ovulation induction

Presentation transcript:

Urinary follicle-stimulating hormone peak as a biomarker for estimating the day of ovulation Hongxia Li, M.D., Jiangang Chen, M.D., James W Overstreet, M.D., Ph.D., Steven T Nakajima, M.D., Bill L Lasley, Ph.D. Fertility and Sterility Volume 77, Issue 5, Pages 961-966 (May 2002) DOI: 10.1016/S0015-0282(02)02998-9

FIGURE 1 Frequency distributions in 20 menstrual cycles of the days of peak hormone concentrations and the DLTs as determined by two algorithms. The data are aligned to the day of follicular collapse (day 0) as determined by serial ultrasonography. Li. Estimating the day of ovulation. Fertil Steril 2002. Fertility and Sterility 2002 77, 961-966DOI: (10.1016/S0015-0282(02)02998-9)